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Abstract: In this study, 4-mercaptobenzoic acid (MBA)-Au nanorods conjugated with a GPR120
antibody were developed as a highly sensitive surface-enhanced Raman spectroscopy (SERS) probe,
and were applied to detect the interaction of fatty acids (FA) and their cognate receptor, GPR120, on the
surface of human embryonic kidney cells (HEK293-GPRR120) cultured in a polydimethylsiloxane
(PDMS) microfluidic device. Importantly, the two dominant characteristic SERS peaks of the Raman
reporter molecule MBA, 1078 cm−1 and 1581 cm−1, do not overlap with the main Raman peaks
from the PDMS substrate when the appropriate spectral scanning range is selected, which effectively
avoided the interference from the PDMS background signals. The proposed microfluidic device
consisted of two parts, that is, the concentration gradient generator (CGG) and the cell culture well
array. The CGG part was fabricated to deliver five concentrations of FA simultaneously. A high
aspect ratio well structure was designed to address the problem of HEK cells vulnerable to shear flow.
The results showed a positive correlation between the SERS peak intensity and the FA concentrations.
This work, for the first time, achieved the simultaneous monitoring of the Raman spectra of cells
and the responses of the receptor in the cells upon the addition of fatty acid. The development of
this method also provides a platform for the monitoring of cell membrane receptors on single-cell
analysis using SERS in a PDMS-based microfluidic device.
Keywords: Raman; SERS; microfluidics; fatty acid; GPR120; 4-mercaptobenzoic acid
1. Introduction
The epidemic of obesity in the Western world has been attributed to several factors, including,
but not limited to, an increase in sedentary lifestyle, socioeconomic factors, and perhaps most
importantly, an overconsumption of nutrients. Of these nutrients, the ingestion of a high fat
diet has been implicated as playing a particularly important role leading to the development of
dietary-induced obesity [1–3]. Recent data from a variety of laboratories have attempted to elucidate
the mechanisms underlying the recognition of dietary fat by the body as a means to eventually try and
pharmacologically target the control of the fat intake. Cognate receptors for dietary fat include a class
of fatty acid-sensitive G protein-coupled receptors [4,5]. The best described of these is the long chain
polyunsaturated fatty acid receptor, GPR120, which mediates the taste (and post-ingestive) recognition
of fat [6]. Mice lacking GPR120 (GPR120 knockouts) show a much-reduced behavioral response to fat
(fatty acids) in the form of a reduced preference for linoleic acid and oleic acid [7,8]. The identification
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of GPR120 in taste cells within the oral cavity, coupled with the ability of taste cells to respond to the
ligands of this receptor, is consistent with these receptors mediating the taste of fat [3]. Development
of imaging capabilities to characterize the response and specificity of these receptors, their distribution,
and the characterization of the effect of ligand binding will facilitate our understanding of the function
of this important class of receptors.
Raman spectroscopy has proven itself as a non-invasive and sensitive detection technique in past
decades. The Raman spectrum provides a molecular fingerprint that could be used to characterize
specific molecules from complex samples. The frequency difference between the incident and emitted
photons is described as the Raman shift, which is unique for individual molecules and is represented
as “cm−1” (inverse of photon wavelength). The peak intensity of the Raman shift is related to the
concentration of the molecules of interest. However, only a small fraction of light (~1 in 106 photons)
is scattered at optical frequencies, usually lower than the frequency of the incident photons (termed
the “Raman effect”). As a result, Raman scattering suffers from low signal intensity. This problem can
be overcome by using surface-enhanced Raman spectroscopy (SERS) [9,10]. SERS is a surface-sensitive
technique that enhances Raman scattering by molecules adsorbed on a rough metal surface (Au and
Ag nano-particles) or by nanostructures (plasmonic–magnetic silica nanotubes). The enhancement
factor can be as much as 106 to 1014. Therefore, SERS has been established as a powerful tool that
can provide insight into the chemical components and into biomaterials with high sensitivity. Many
excellent reviews describing SERS and its principles are available [11–13].
Microfluidics is currently a highly active field, particularly in the context of lab-on-a-chip (LOC)
systems. The use of microfluidics to conduct biomedical and clinical research has a variety of
advantages. It offers automation, miniaturization, high-throughput, nanoliter scaled sample volumes,
and a large surface area-to-volume ratio [14,15]. Combining Raman with microfluidics allows for
the accurate monitoring, analysis, and detection of a wide range of samples in micro-environments.
So far, microfluidic platforms integrated with SERS for biochemical analysis have been extensively
reported [16–24]. One of the major challenges of combining microfluidics and Raman spectroscopy is
the strong background from substrates. Materials such as polydimethylsiloxane (PDMS), glass, and
Poly(methyl methacrylate) (PMMA) are widely used for the fabrication of microfluidics because of
their favorable optical properties and ease of bonding. However, they are Raman active polymers,
which have their own Raman scattering signal. Many methods were recently reported to minimize the
background from these materials. Substrate materials with a low Raman background such as MgF2 [25],
CaF2 [26], and quartz [27] were employed as substitutes. However, the cost of these materials is high
and the prototyping and bonding presents another technical challenge. Integrated laser fibers within
microfluidics are also reported as an alternative method to avoid the background [28]. Nevertheless,
the scale of the application remains limited and the fabrication cost high.
Here, we developed a 3D microfluidic device for the detection of fatty acid-induced GPR120 receptors
using SERS. The device is comprised of two connected functional parts, namely: the concentration gradient
generator (CGG) and the micro-well cell culture array. Compared with conventional dish culture methods,
monitoring the cell response to fatty acids in our microfluidic device is high-throughput and low-cost.
The CGG could deliver five different concentrations of FA simultaneously to 25 wells, eliminating the
adaptation problems associated with repeated, sequential stimulations on individual cells. In addition,
the entire device was several cm in length and the volume of each microwell was 3.14 µL, and
hence, the fabrication cost and reagent consumption were much less. The 4-mercaptobenzoic acid
(MBA) SERS probe was introduced so as to avoid the problems associated with the PMDS substrate
background. The SERS spectra were collected to analyze the HEK cell GPR120 receptor response to
different concentrations of FA. This method, for the first time, realizes the capability of the simultaneous
measurement of the representative native cell peaks and the time-dependent fatty acid interaction
with its specific receptor in a microfluidic environment, and also provides a platform for biochemical
measurement using SERS in a PDMS-based device.
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2. Materials and Methods
2.1. Materials
The 4-mercaptobenzoic acid (MBA), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride
(EDC), N-hydroxysuccinimide (NHS), and doxycycline hydrochloride (DOX) were purchased from
Sigma-Aldrich (St Louis, MO, USA). Blasticidin S HCl, hygromycin B, phosphate-buffered saline (PBS),
and 0.5% trypsin–EDTA were purchased from Life Technologies (Carlsbad, CA, USA). Polyethylene
glycol (PEG) products, thiol PEG acid (HS–PEG–COOH, MW 5000), and methoxyl PEG-thiol
(mPEG–SH, MW 5000), were purchased from Nanocs Inc. (New York, NY, USA). The monoclonal
GPR120 antibody was purchased from Santa Cruz Biotechnology Inc. (sc-99105). The linoleic acid was
obtained from Sigma Chemical Co. (St. Louis, MO, USA). Ultrapure water (18 MΩ cm−1) was used in
this work.
2.2. Device Fabrication
The fabrication steps for both parts are illustrated in Figure 1a,b. The concentration gradient
generator was fabricated using photolithography. The channel height and width were designed to 50
µm and 200 µm, respectively. The SU-8 2025 negative photoresist (Microchem®, Westborough, MA,
USA) was spin coated on a three-inch diameter silicon wafer at a speed of 1800 rpm. The soft bake time
was 3 min at 65 ◦C and 10 min at 95 ◦C. A transparency mask was printed at CAD/Art Services, Inc.
(Portland, OR, USA) for the UV exposure. The post exposure bake time was 2 min at 65 ◦C and 7 min
at 95 ◦C. PDMS soft lithography was applied in order to obtain the final device. The PDMS was mixed
in a 10:1 ratio, stirred vigorously for 5 min, and then degassed for 30 min under dynamic vacuum to
remove all air bubbles, and was cured at 60 ◦C for 2 h. The micro-well array part was replicated from
a 3D printed master mold. The 3D master mold was fabricated using high-resolution acrylonitrile
butadiene styrene (ABS), and a stereolithography (SLA) technique from 3D SYSTEM Inc. (Goleta, CA,
USA). The total channel height was 1200µm (top flow channel 200 µm and bottom well 1000 µm) and
the width was 1000 µm. Finally, the replicated PDMS layers were sealed by oxygen plasma etching at
50 W, for 30 s. The experimental setup for the detection of GPR120 by SERS is shown in Figure 1c.
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2.3. Device Sterilization and Cell Seeding
The cell culture well array was assembled and sterilized by autoclaving for 20 min under 121 ◦C,
after sterilization, ethanol was flowed through the channels at 30 µL/min for 30 min, followed by a PBS
wash. The channels were tested for leakage by flowing food dye through the microchannel. Finally,
the device was coated with fetal bovine serum overnight at 4 ◦C in fridge. The cells were trypsinized
and fully suspended by vortex (Corning LSE) before injection to the microchannels. A 1 mL syringe
(B-D®) was used for cell injection into the microfluidic well array culture chamber. The seeding density
for all of the cell types was 5000 cells/cm2
2.4. Cell Preparation
Human embryonic kidney cells (HEK293) were kindly provided by International Flavors and
Fragrances Inc. (IFF). The HEK293 cell lines transfected with an inducible GPR120 gene (HEK293-
GPR120) were used in this context. The cells were grown in DMEM-GlutaMAX media (Life Technologies,
10569-010) supplemented with 10% Tet-free fetal bovine serum (Fisher, NC0290780). The cells were
cultured in a humidified atmosphere at 37 ◦C with 5% CO2, and were passaged at over 75% confluence.
Blasticidin S HCl (10 µg mL−1) and hygromycin B (100 µg mL−1) were added to the cell culture
medium specifically for the maintenance of the inducible GPR120 gene.
2.5. In-Device Cell Culture and Fatty Acid Treatment
To evaluate the biocompatibility of the microfluidic device, HEK293-GPR120 cells were cultured
in the PDMS device for a period of two days. The cells were injected manually to a microwell array
culture chamber, and the entire device was placed in an incubator after seeding in a 5% CO2, 37 ◦C
environment. To induce the expression of GPR120, a culture media with DOX at 0.5 µg mL−1 was
used in the device for 48 h. The medium was refreshed every 24 h. The cell images were collected
after the medium was replaced. After the 48-h incubation in the device, the CGG part of the device
was connected to the well array part by tubing, and the linoleic acid and PBS buffer (1x) solution
were injected into the CGG part through two inlets, using syringe pump at a speed of 50 µL /min for
5 min. After another 5 min treatment, the antibody-conjugated gold nanorods (AuNRs; SERS probe) in
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the culture medium were injected to wash out the previous solution, and were kept in an incubator
overnight to ensure the completion of the GPR120 antibody and receptor binding.
2.6. Synthesis of SERS Probe
The steps for the MBA-AuNR-antibody preparation are illustrated in Figure S1. First, 1 mL of
a gold nanorod (AuNR) (Nanopartz Inc., Loveland, CO, USA) solution was mixed with an MBA
solution (1 mM, 10 µL) and was incubated for 30 min. Solutions of HS–PEG–COOH (1 mg mL−1,
10 µL) and mPEG–SH (1 mg mL−1, 40 µL) were sequentially added to the nanorod solution and were
incubated for 2 h. Then, the resultant solution was centrifuged (12,000 g, 15 min) to remove the excess
PEG and MBA. The particles were re-suspended in water. Freshly prepared EDC (10 mM, 10 µL) and
NHS (25 mM, 10 µL) solutions were mixed with the nanorod solution and were allowed to react for
30 min. The resulting solution was centrifuged, and the particles were re-suspended in PBS. At last,
the anti-GPR120 antibody (0.2 mg mL−1, 10 µL) was added to the nanorod solution and was incubated
for 1 h. Excess antibody was removed by centrifugation. The nanorods were re-suspended in PBS.
The functionalized nanoprobe (MBA-AuNR-antibody) was stable in a solution for several days at 4 ◦C.
2.7. Raman Spectroscopy Measurement
The Raman spectra were measured using a Renishaw inVia Raman spectrometer, equipped
with a 785 nm near-IR laser, which was focused through a 50× long working distance lens (Leica
Microsystems). The laser intensity before and after travelling through the 50× objective was 110 mW
and 29.4 mW, respectively (measured with LaserCheck, Coherent Inc., Portland, OR, USA). The grating
used was 1200 L/mm. A silicon wafer was used for calibration before data collection (adjusted to
520.5 ± 0.1 cm−1 for the silicon peak). The HEK293 cells were cultured in the PDMS microfluidic
device for 48 h, and the Raman measurement was conducted for the cells in a PBS buffer. The Raman
spectra were collected over the range of 950 cm−1 to 1150 cm−1. The exposure time was 10 s for one
accumulation at 100% laser power for all of the cell samples. The system spectral resolution was
1 cm−1. The cosmic rays in the raw spectra were removed using the “zap” function in Renishaw WIRE
3.4 software.
3. Results and Discussion
3.1. High Aspect Ratio Well Structure Evaluation
Because of the poor adhesion ability of HEK293 cell line, the cells were easily detached under shear
flow in the microfluidic environment. To address this issue, the high aspect ratio micro-well structure
was 3D printed and replicated by PDMS molding. The cell proliferation in the deep wells could
prevent the detachment of cells during media refreshment and fatty acid injection. The dimensions of
the well unit are illustrated in Figure 2a,b. The flow rate profile within the channel and microwell was
simulated with COMSOL Multiphysics 5.2a (COMSOL Inc., Palo Alto, CA, USA). Three assumptions
were made to mimic the actual flow situation, including the following: (1) the fluid is Newtonian,
(2) no-slip boundary condition, and (3) the flow within the channel is incompressible. The 3D model
was created initially in AutoCAD 2016 (Autodesk Inc., San Rafael, CA, USA), and then imported
into the COMSOL library. The simulation was performed using physical interfaces laminar flow (spf)
under the stationary study model. The inlet velocity flow was set to 40 µL/min. The simulation results
are illustrated in Figure 2c. The flow speed reduced by 30.16 times from 1.93 mm/s to 0.064 mm/s
(selected data collection points were 10 µm above the PDMS surface at cross-section plane A and B).
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3.2. Evaluation of CGG
The two fabricated parts and combined devices are illustrated in Figure 3. The blue color food
dye was injected into the CGG part using a syringe pump at speeds of 200 µL/min, 100 µL/min, and
50 µL/min for 5 min. The gradient output streams were collected and evaluated by spectrophotometry.
The results are summarized in Figure S2 and Table S1. The color intensities of the output streams were
close to the corresponding standard solutions. The flow rate at 50 µL/min showed the most accurate
concentration distribution. The errors could be caused by many factors, such as the uneven thickness
of the photoresist on the fabricated master mold; trapped bubbles in the syringe, needle, or device
during pumping; imperfection of hole punching for needle connection; and deviation of the tubing
length. Based on the spectrophotometric results, the flow rate of 50 µL/min was chosen to generate
the fatty acid concentration gradient for treatment.
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be expected to increase the MBA SERS signal upon binding between the anti-GPR120 antibody 
conjugated on nanorods and its antigen GPR120 on the cell surface. While the mechanism for this 
Figure 3. Current microfluidic device setup for GPR120 receptor detection; (a) two parts connected by
tubing; (b) concentration gradient generator at a flow rate of 50 µL/min; (c) human embryonic kidney
cell lines transfected with an inducible GPR120 gene (HEK293-GPR120) cell cultured in a well array.
3.3. Cell Culture in Device
To evaluate the device biocompatibility, HEK293 cells were placed in a culture and were induced
by DOX in the device for two days before the LA treatment. Figure 4 presents the results of the cells
cultured in the microfluidic device at the time points of seeding, 24 h and 48 h under 5× and 10×
magnification. It can be seen that the HEK293-GPR120 cells were grown and reached approximately
70% confluence on day 3. In addition, almost all of the cells attached to the substrate (Figure 4; 5× and
10×; 48 h), and relatively few suspended cells were observed. The results indicated that our device
addressed the cell detachment issue and was biocompatible for the HEK293 cells.
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3.4. SERS Measurement
Our previous research [29] is consistent with the interpretation that the FA treatment will increase
the number of functional GRP120 receptors expressed on the cell surface, and hence would be expected
to increase the MBA SERS signal upon binding between the anti-GPR120 antibody conjugated on
nanorods and its antigen GPR120 on the cell surface. While the mechanism for this increased signal
has not been elucidated, the binding of FAs to the receptor may induce a conformational change
that facilitates the subsequent binding of the SERS probe or FAs themselves, and may facilitate the
functional expression of previously quiescent receptors in the membrane. SERS has been proven to have
the ability to detect the conformation change of DNA and protein receptors by several groups [30–33].
The main challenge of combining PDMS microfluidics and Raman spectroscopy is the strong
background from PDMS (black curve, in Figure 5). Two dominant MBA specific peaks are presented at
1078 cm−1 and 1582 cm−1 (red curve, in Figure 5), which do not overlap with the PDMS background
signal (cyan color highlighted zone in Figure 5). This is the major reason that the MBA was chosen as a
Raman reporter molecule for the SERS probe construction in this work. Moreover, based on Figure 5,
the counts of the PMDS baseline ranged from 2000 to 13,000, even in the area without visible peaks.
HEK cell peaks with low counts would be hard to detect accurately in areas overlapping with the
strong baseline. The HEK cell peaks with relatively high counts are marked in Figure S3. The peaks
at 621 cm−1 and 1259 cm−1 are assigned to the C–C twisting mode of phenylalanine and amide III,
respectively; both are protein bands. The peak at 787 cm−1 is assigned to DNA, it can be taken as
a measure for the relative quantity of nucleic acids present. The peaks at 1301 cm−1 and 1447 cm−1
are assigned for the lipid and CH2 bending mode of proteins and lipids, respectively [34]. The peak
at 1002 cm−1 represents phenylalanine. In most cases, the peak at 1002 cm−1 is one of the highest
peaks, close to the MBA peak at 1078 cm−1 in a HEK293 cell spectrum [35–38]. In order to increase
the signal-to-noise ratio, 1002 cm−1 was selected to represent a native cell peak as a comparison
to the MBA peak (1078 cm−1). In addition, as shown in Figure S3, the other MBA SERS peak at
1582 cm−1 was much weaker and overlapped with the two strong peaks of amide II (1557 cm−1) and
amide I (1656 cm−1) from the cells, which made it impossible to be accurately analyzed independently.
Statistically, compared with the control group (normal culture), the average counts from the treatment
group (treated with 60 µm linoleic acid, followed by incubation with the MBA-AuNRs-antibody) were
increased from 780 (standard deviation (SD) = 204) to 2872 (SD = 2914) for 1078 cm−1, and 1202 (SD =
184) to 2183 (SD = 1356) for peak 1582 cm−1, respectively. Apparently, a larger peak increment was
observed at 1078 cm−1. Taken together, in this study, the Raman spectra were collected from a range of
950 cm−1 to 1150 cm−1. This selected scanning range brings the opportunity to monitor the responses
from the native cell peak (1002 cm−1) and the SERS peak (1078 cm−1) from the SERS probe conjugated
with a specific antibody to receptor GRP120. By monitoring these peak changes (primarily intensity
changes), the influence of fatty acids on the cell itself and the interaction between fatty acid and its
receptor GPR120 could be detected simultaneously in the selected scan range.
The last step in this approach was to examine the cell response to the different concentrations of
linoleic acid (LA) introduced to a cell culture device (Figure 6a). The HEK293-GPR120 cells were seeded
and induced by DOX for 48 h. Different fatty acid concentrations were applied to different channels of
microfluidic wells (0 µM, 15 µM, 30 µM, 45 µM, and 60 µM), the treatment time was 5 min and the
unbound LA was washed off by injection of the media. After injection of the MBA-AuNRs-antibody
SERS probes, the device was put back into the incubator for 12 h before the SERS measurement.
The stability and reproducibility of the MBA SERS signal were evaluated before the SERS cell assay.
The MBA-AuNRs were pipetted onto an MgF2 slice and left to dry for 30 min. The SERS peaks at
1078 cm−1 were collected from eight different spots (five replications at each spot) using a long working
distance objective (50×). The result is shown in Figure S4; the counts of the parallel tests from the same
spot were close to each other (Figure S4a). However, a large variation of counts was also observed
at different collection spots (Figure S4b). The reason for the different peak heights in Figure S4b is
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because the SERS measurement is highly sensitive to the local environment that the incident laser
interacts with (e.g., nanoparticle intensity, incident laser angles, and so on [11–13].
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The SERS measurement of the cells in response to the different concentrations of LA is given in
Figure 6b. Thirty-five spectra were collected from each treatment group; each spectrum was collected
from different individual cell. Seven cells were randomly selected from each well (five wells for
each concentration). The baseline was removed using built-in functions of the WIRE3.4 software.
The arithmetic mean value of the counts from all of the samples was used to evaluate the correlation
of the MBA peak to the LA treatment concentration. It was found that the SERS peak intensity (at
1078 cm−1) was positively correlated to the LA concentration, validating our previous observation that
was conducted in a culture dish [29]; while the heights of the two peaks at 988 cm−1 and 1002 cm−1
appeared independent of the LA concentration (Figure 6c). The 1078 cm−1 average peak counts were
1549.39, 1784.20, 2035.73, 2232.12, and 3207.53 for LA treatment concentration 0 µM, 15 µM, 30 µM,
45 µM, and 60 µM, respectively. The SERS intensities at 1078 cm−1 vs. the LA concentration are
plotted in Figure 6c. A linear (R2 = 0.931) increase in the 1078 cm−1 intensity was observed with the
increased LA concentrations. These results also demonstrated the potential use of SERS to study the
dynamic process of the biomolecules in single living cells. The relative standard deviations (RSD)
of the sample spectra counts for different LA treatment groups—0 µM, 15 µM, 30 µM, 45 µM, and
60 µM—were 15.9% 22.0% 16.9% 23.7%, and 29.4% for peak 1002 cm−1, and 31.1% 40.9% 42.5% 33.3%,
and 70.8% for peak 1078 cm−1. This large RSD at peak 1078 cm−1 could be caused by the dispersive
counts distribution of the spectra collected from the cell surface (Figure 6d). Notably, in the 60 µM
group (Figure 6d), two apparent populations are clearly visible. It is unclear why this happened.
This phenomenon could be accounted for in a couple of ways, namely: the cell-to-cell variation of the
in response to high concentrations of FA (e.g., 60 µM); or some cells expressing more GPR120 receptors
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would have a greater likelihood of being bound with anti-GPR120 SERS probes, leading to higher
counts of signal. One-way Analysis of variance (ANOVA) was conducted with the confidence level of
95% (Figure S5), the Raman counts of 60 µM vs. 45 µM, 60 µM vs. 30 µM, 60 µM vs. 15 µM, 60 µM
vs. 0 µM, and 45 µM vs. 0 µM were found to be significantly different. However, groups 45 µM vs.
30 µM, 45 µM vs. 15 µM, 30 µM vs. 15 µM, 30 µM vs. 0 µM, and 15 µM vs. 0 µM were not significantly
different. The results of the non-significant differences can be caused by the close mean value of the
paired groups and the relatively large RSD due to the non-uniform dispersive counts distribution.
The ANOVA results also suggested that the cell responses were not strong enough to distinguish the
corresponding concentration range (0–45 µM) of LA treatments with the increment of 15 µM, especially,
under a large RSD. The counts distribution for each sample from the different treatment groups were
demonstrated in Figure 6d. The sampling locations on the cell surface were randomly selected during
the SERS data collection. Although there was a trend that higher LA concentrations lead to higher
SERS responses, the variation of the SERS peak intensity for the same LA treatment concentration can
be appreciable because of the cell’s non-uniform response to LA. For example, several high counts
(7000–9000) were observed at the channel treated with 60 µM LA, on the other hand, several samples
in each group had extremely low or even no detectable response to the treatment. The possible reasons
could be that (1) some cells were resistant to the LA treatment, and a low or no SERS signal would be
detected while focusing anywhere on these cell surface. (2) Not all of the GPR120 receptors on the
HEK-GPR120 cells were activated by the LA treatment, thus the active zone may be only on certain
sub-regions of the cell surface.
Raman spectral mapping was employed for the visualization of the GPR120 receptor distribution
on the single HEK293 cell surface (Figure 7). The mapping was conducted using HEK293-GRP120
cells cultured on MgF2, induced by DOX for 48 h, followed by the addition of 60 µM LA for 5 min,
before being incubated with the SERS probe for 12 h. The blue color intensity was proportional to
the SERS signal at 1078 cm−1 from the MBA reporter molecules. Three spots (a, b, and c) in Figure 7c
were randomly selected to show the spectra at these locations. It was found that no SERS signal was
detected at the area without cells attached (spot-c), the stronger color intensity (spot a) exhibits the
higher color SERS peaks (spot b). These mapping results demonstrate that the MBA SERS probes were
bound on the surface of most cells, however, the distribution of the bound receptors was not uniform
over the entire cell surface. If a spectrum sample was collected from the cell area with no bound
SERS probe, no detectable SERS signal would be seen. If the laser spot partially covered the activated
area during the spectra collection, the signal can be extremely low. This diverse signal variation may
explain the observation in Figure 6d.
The spectra comparison between the signals (950 cm−1–1150 cm−1) acquired in the RDMS
microfluidic wells and in the conventional dish culture on the MgF2 slices is illustrated in Figure S6.
The PDMS substrate would cause a Raman laser power attenuation while laser travels through the
top PDMS layer. The average counts of peak 1002 cm−1 and 1078 cm−1 declined to approximately
45.9% and 56.8%, respectively, compared to those obtained from the cells cultured on the MgF2 slice.
However, the signal attenuation in the device was acceptable (due to two well defined MBA SERS
peaks), and the intensity detected from the PDMS device was still adequate for analysis.
Our results are consistent with the interpretation that the fatty acids alone do not alter the surface
structure of the cells, as noted from the lack of effect on the cell-related peaks. Instead, the fatty acid,
as expected, appears to preferentially bind with the GPR120 receptor. It is clear that it was possible,
using this approach, to monitor the interaction between the fatty acid and its cognate receptor by
assessing the SERS peak from the anti-GPR120 antibody conjugated SERS probe. Prior to the addition
of the SERS probe, the fatty acid binds a specific, though presently undetermined, region of the GPR120
receptor. Anti-GPR120 antibody (which is conjugated on the SERS nanorods surface) recognizes the
extracellular epitope of the GRP120 receptor. The addition of the SERS probe and the subsequent
antibody-antigen binding would lead to the conformation changes of the fatty acid and/or GPR120
receptor or their complex, which, in return, alters the local environment of the exposed SERS probe.
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The local environmental changes would give rise to the SERS peak changes. Simply, the more fatty
acid molecules added, the more GPR120 receptors would be bound, thus the more SERS probes
would recognize GPR120 receptors. Thus, this would be reflected in the higher SERS peaks. More
experiments are needed in order to elucidate the specific mechanisms of interaction. Importantly,
these series of experiments represent the first successful simultaneously monitoring of Raman spectra
of cells (1002 cm−1) and the receptor-fatty acid interaction (1078 cm−1) in cells using a fabricated
microfluidic device.
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4. Conclusions
In this study, a PDMS integrating a concentration gradient generator (CGG) with the capability
of delivering five concentrations of LA at a time and a micro-well array cell culture chamber was
fabricated and tested in the detection of the presence of the GRP120 receptors and its interaction with
fatty acid. The concentration generated in each CGG channel in the microfluidic device was evaluated
by spectrophotometry with food dye. A 3D printed master mold was used for the fabrication of
high aspect ratio micro-well cell culture array, to minimize the problem of HEK293 cell detachment
under flow shear. The cell was cultured and induced in the device by DOX, for 48 h before the Raman
measurement. An MBA-AuNR-GPR120-antibody-based SERS probe was constructed and employed to
detect the GPR120 expression on the single HEK293 cell surface and the SERS probe, also to effectively
avoid the interference from the PDMS background signal, when the appropriate spectral scanning
range is selected. This microfluidic device, for the first time, achieves a simultaneous measurement of
the representative Raman peaks from cells and the fatty acid interaction with specific receptor. Using
this device and the SERS probes, we evaluated the dependence of the characteristic SERS peak height
on the concentration of the fatty acid (LA). It was found that the SERS peak intensities were positively
correlated to the LA treatment concentrations. The receptor distribution on a single cell level was also
visualized by Raman mapping.
Supplementary Materials: The following are available online at http://www.mdpi.com/1424-8220/19/7/1663/
s1: Figure S1: Schematic of MBA-AuNR-antibody preparation steps; Figure S2: The concentrations gradient
distribution using food dy with different injection flow rates; Figure S3: Represen ative Rama spectra of
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HEK293-GPR120 cell culture on a MgF2 slide (normal culture (blue) and cultured with MBA-AuNRs-antibody
(treated with 60 µm linoleic acid) (red)); Figure S4: Stability and reproducibility of the MBA SERS; Figure S5:
one-way ANOVA analysis of the counts at MBA peak 1078 cm−1 with different LA treatment concentrations, 95%
confidence level (n = 30–35); Figure S6: Comparison of the peaks at 1002 cm−1 and 1078 cm−1 from HEK293 cells
cultured in a dish and in a microfluidic device, the FA treatment concentration was 60 µM; Table S1: The relative
percentage of the output streams with different flow rates (n = 3).
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